v3.26.1
Stock Compensation Plan (Tables)
 6 Months Ended
Jun. 30, 2026
Stock Compensation Plan  
Schedule of Company's Stock Options

The following table sets forth the activity for the Company’s stock options during the periods presented:

 

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price
per Share

 

 

Weighted
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2025

 

 

808,000

 

 

$

3.06

 

 

 

7.3

 

 

$

2,020,050

 

Exercised

 

 

(62,766

)

 

$

2.21

 

 

 

 

 

 

 

Forfeited

 

 

(14,669

)

 

$

6.16

 

 

 

 

 

 

 

Outstanding as of June 30, 2026

 

 

730,565

 

 

$

3.07

 

 

 

6.8

 

 

$

2,304,378

 

Exercisable as of June 30, 2026

 

 

580,663

 

 

$

2.27

 

 

 

6.2

 

 

$

2,295,384

 

Vested or expected to vest as of June 30, 2026

 

 

730,565

 

 

$

3.07

 

 

 

6.8

 

 

$

2,304,378

 
Schedule of Summarizes Vesting of Restricted Common Stock

The following table summarizes vesting of restricted common stock:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value
Per Share

 

Unvested as of December 31, 2025

 

 

4,169,955

 

 

$

5.68

 

Granted

 

 

4,273,555

 

 

$

7.70

 

Vested

 

 

(1,428,693

)

 

$

6.84

 

Forfeited

 

 

(135,394

)

 

$

7.30

 

Unvested as of June 30, 2026

 

 

6,879,423

 

 

$

6.70

 

 
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for all stock awards recognized in the accompanying condensed consolidated statements of operations and comprehensive loss is as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Selling, general and administrative

 

$

4,344

 

 

$

4,379

 

 

$

8,505

 

 

$

6,198

 

Research and development

 

 

198

 

 

 

50

 

 

 

449

 

 

 

121

 

Total

 

$

4,542

 

 

$

4,429

 

 

$

8,954

 

 

$

6,319